Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed May 9, 2018 · 10-Q · 39 days after period end · 0001069530-18-000023
| Metric | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 |
|---|---|---|---|---|
| Net Income | -$2.16M | -$2.74M | -$5.80M | -$2.58M |
| EPS Diluted | -$0.33 | -$0.42 | -$0.13 | -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Mar 31, 2018 · filed May 9, 2018 · 39 d after period end
